chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Hypersensitivity
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE HYPOXEMIC RESPIRATORY FAILURE ALLERGIC REACTION, INIT
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Thought the Expiration date was.  6/30/23, but it was the be used by 5/22/23. The vaccine was given on 5/26/23 . I did have njurse check with me before giving the vaccine.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Asthenia, COVID-19, COVID-19 pneumonia, Confusional state
Clinical narrative: Patient seen in the ED on 2/9/23 for cough, weakness, shortness of breath, and 'right ear crackling' that started the day prior. She had a known COVID exposure three days prior. She tested positive for COVID-19 by PCR, and was discharged with a prescription of Paxlovid. She returned to the ED on 2/11/23 for confusion and shortness of breath. She was admitted 2/11 - 2/16 with discharge diagnoses including acute respiratory failure with hypoxia due to severe COVID-19 viral pneumonia. During admission, she was on supplemental oxygen, but ultimately was able to be weaned off prior to discharge. She was also started on Decadron during her admission. Of note, the patient has completed the primary COVID vaccine series and a booster but had not received the bivalent vaccine at time of admission.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, Exposure to SARS-CoV-2, SARS-CoV-2 test positive, Tinnitus
Clinical narrative: Patient seen in the ED on 2/9/23 for cough, weakness, shortness of breath, and 'right ear crackling' that started the day prior. She had a known COVID exposure three days prior. She tested positive for COVID-19 by PCR, and was discharged with a prescription of Paxlovid. She returned to the ED on 2/11/23 for confusion and shortness of breath. She was admitted 2/11 - 2/16 with discharge diagnoses including acute respiratory failure with hypoxia due to severe COVID-19 viral pneumonia. During admission, she was on supplemental oxygen, but ultimately was able to be weaned off prior to discharge. She was also started on Decadron during her admission. Of note, the patient has completed the primary COVID vaccine series and a booster but had not received the bivalent vaccine at time of admission.
Age: 79.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: VACCINE ADMINISTERED OUTSIDE OF THE SUGGESTED ADMINISTRATION DATE OF USE
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: hospitalized with covid; fully vaccinated
Age: 18.0
Sex: F
Vaccine: MMR, MMR
Symptoms: Chills, Communication disorder, Fatigue, Feeling abnormal, Headache
Clinical narrative: While still seated almost immediately after vaccination, arm felt tingling and pain and tingling shot up through the hand into head.  Fuzzy feeling, couldn't communicate well, tried to talk. Hands started and legs started to shake. Went completely limp and passed out in chair. Approximately 5 minutes out? Came back to consciousness and was thirsty, headache, loss of color,  didn't know that she lost consciousness. We gave her Benadryl as soon as she was able to take it after the reaction. Arm felt huge but did not seem to show any swelling. We had her lie down on bench for approximately 20 minutes and she felt better, color started to come back. Whole arm felt "blown up" like a balloon for a couple hours. She felt tired and has the chills on and off  as of today's date (06/02/2023).
Age: 18.0
Sex: F
Vaccine: MMR, MMR
Symptoms: Hypotonia, Immediate post-injection reaction, Loss of consciousness, Pain, Pain in extremity
Clinical narrative: While still seated almost immediately after vaccination, arm felt tingling and pain and tingling shot up through the hand into head.  Fuzzy feeling, couldn't communicate well, tried to talk. Hands started and legs started to shake. Went completely limp and passed out in chair. Approximately 5 minutes out? Came back to consciousness and was thirsty, headache, loss of color,  didn't know that she lost consciousness. We gave her Benadryl as soon as she was able to take it after the reaction. Arm felt huge but did not seem to show any swelling. We had her lie down on bench for approximately 20 minutes and she felt better, color started to come back. Whole arm felt "blown up" like a balloon for a couple hours. She felt tired and has the chills on and off  as of today's date (06/02/2023).
Age: 18.0
Sex: F
Vaccine: MMR, MMR
Symptoms: Pallor, Paraesthesia, Speech disorder, Swelling, Thirst
Clinical narrative: While still seated almost immediately after vaccination, arm felt tingling and pain and tingling shot up through the hand into head.  Fuzzy feeling, couldn't communicate well, tried to talk. Hands started and legs started to shake. Went completely limp and passed out in chair. Approximately 5 minutes out? Came back to consciousness and was thirsty, headache, loss of color,  didn't know that she lost consciousness. We gave her Benadryl as soon as she was able to take it after the reaction. Arm felt huge but did not seem to show any swelling. We had her lie down on bench for approximately 20 minutes and she felt better, color started to come back. Whole arm felt "blown up" like a balloon for a couple hours. She felt tired and has the chills on and off  as of today's date (06/02/2023).
Age: 18.0
Sex: F
Vaccine: MMR, MMR
Symptoms: Tremor
Clinical narrative: While still seated almost immediately after vaccination, arm felt tingling and pain and tingling shot up through the hand into head.  Fuzzy feeling, couldn't communicate well, tried to talk. Hands started and legs started to shake. Went completely limp and passed out in chair. Approximately 5 minutes out? Came back to consciousness and was thirsty, headache, loss of color,  didn't know that she lost consciousness. We gave her Benadryl as soon as she was able to take it after the reaction. Arm felt huge but did not seem to show any swelling. We had her lie down on bench for approximately 20 minutes and she felt better, color started to come back. Whole arm felt "blown up" like a balloon for a couple hours. She felt tired and has the chills on and off  as of today's date (06/02/2023).
Age: 18.0
Sex: F
Vaccine: MMR, MMR
Symptoms: Aphasia, Chills, Feeling abnormal, Headache, Loss of consciousness
Clinical narrative: While still seated almost immediately after vaccination, arm felt tingling and pain and tingling shot up through the hand into head.  Fuzzy feeling, couldn't communicate well, tried to talk. Hands started and legs started to shake. Went completely limp and passed out in chair. Approximately 5 minutes out? Came back to consciousness and was thirsty, headache, loss of color,  didn't know that she lost consciousness. We gave her Benadryl as soon as she was able to take it after the reaction. Arm felt huge but did not seem to show any swelling. We had her lie down on bench for approximately 20 minutes and she felt better, color started to come back. Whole arm felt "blown up" like a balloon for a couple hours. She felt tired and has the chills on and off  as of today's date (06/02/2023).
Age: 18.0
Sex: F
Vaccine: MMR, MMR
Symptoms: Lymphadenopathy, Pain in extremity, Pallor, Paraesthesia, Thirst
Clinical narrative: While still seated almost immediately after vaccination, arm felt tingling and pain and tingling shot up through the hand into head.  Fuzzy feeling, couldn't communicate well, tried to talk. Hands started and legs started to shake. Went completely limp and passed out in chair. Approximately 5 minutes out? Came back to consciousness and was thirsty, headache, loss of color,  didn't know that she lost consciousness. We gave her Benadryl as soon as she was able to take it after the reaction. Arm felt huge but did not seem to show any swelling. We had her lie down on bench for approximately 20 minutes and she felt better, color started to come back. Whole arm felt "blown up" like a balloon for a couple hours. She felt tired and has the chills on and off  as of today's date (06/02/2023).
Age: 1.0
Sex: M
Vaccine: HEPA, MMRV
Symptoms: No adverse event, Wrong product administered
Clinical narrative: 1yr M presented for well child visit. MMR vaccination ordered without varicella vaccination. Patient was given ProQuad instead. Patient did not experience any adverse side effects from this.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Atrial fibrillation, COVID-19, Chest pain, Chills, Condition aggravated
Clinical narrative: Patient with history of diabetes type II, CKD, and Afib with RVR. She was brought to the ED by EMS on 2/16/23 for shortness of breath. She has been feeling ill for the past week and a half, and reports symptoms of chest pain, shortness of breath, cough, chills, nausea, and diarrhea. In the ED, she was found to be in atrial fibrillation with RVR and had a positive COVID-19 PCR test. She was admitted 2/16/23 - 2/22/23 for atrial fibrillation with RVR in the setting of COVID-19 infection. She was treated with IV dexamethasone during admission. Per the chart, the patient has received the primary COVID vaccine series and two booster doses.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Diarrhoea, Dyspnoea, Malaise, Nausea
Clinical narrative: Patient with history of diabetes type II, CKD, and Afib with RVR. She was brought to the ED by EMS on 2/16/23 for shortness of breath. She has been feeling ill for the past week and a half, and reports symptoms of chest pain, shortness of breath, cough, chills, nausea, and diarrhea. In the ED, she was found to be in atrial fibrillation with RVR and had a positive COVID-19 PCR test. She was admitted 2/16/23 - 2/22/23 for atrial fibrillation with RVR in the setting of COVID-19 infection. She was treated with IV dexamethasone during admission. Per the chart, the patient has received the primary COVID vaccine series and two booster doses.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Patient with history of diabetes type II, CKD, and Afib with RVR. She was brought to the ED by EMS on 2/16/23 for shortness of breath. She has been feeling ill for the past week and a half, and reports symptoms of chest pain, shortness of breath, cough, chills, nausea, and diarrhea. In the ED, she was found to be in atrial fibrillation with RVR and had a positive COVID-19 PCR test. She was admitted 2/16/23 - 2/22/23 for atrial fibrillation with RVR in the setting of COVID-19 infection. She was treated with IV dexamethasone during admission. Per the chart, the patient has received the primary COVID vaccine series and two booster doses.
Age: 72.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: VACCINE ADMINISTERED OUTSIDE OF THE SUGGESTED ADMINISTRATION DATE OF USE.
Age: 95.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, COVID-19 pneumonia, Death, Fall
Clinical narrative: Patient with history of atrial fibrillation, dementia, CKD, and stroke. He was brought to the ED by EMS on 2/20/23 for lethargy and weakness as noted by his nursing home staff. Per EMS, the patient had a fall the day prior but was evaluated by EMS and was determined he could stay home. He was found to have a fever with a temp of 104.2. A COVID PCR test performed in the ED resulted positive. He was admitted 2/20-2/28. He was diagnosed with COVID-pneumonia and superimposed bacterial pneumonia. Initially he was treated with broad spectrum antibiotics and steroids with improvement in symptoms, however the patient's condition worsened on 2/25. He had increased oxygen needs during his admission, and ultimately was transitioned to comfort cares on 2/27. He passed away on 2/28/23. The patient received the primary COVID vaccine series and one booster dose.
Age: 95.0
Sex: M
Vaccine: COVID19
Symptoms: General physical health deterioration, Lethargy, Pneumonia bacterial, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Patient with history of atrial fibrillation, dementia, CKD, and stroke. He was brought to the ED by EMS on 2/20/23 for lethargy and weakness as noted by his nursing home staff. Per EMS, the patient had a fall the day prior but was evaluated by EMS and was determined he could stay home. He was found to have a fever with a temp of 104.2. A COVID PCR test performed in the ED resulted positive. He was admitted 2/20-2/28. He was diagnosed with COVID-pneumonia and superimposed bacterial pneumonia. Initially he was treated with broad spectrum antibiotics and steroids with improvement in symptoms, however the patient's condition worsened on 2/25. He had increased oxygen needs during his admission, and ultimately was transitioned to comfort cares on 2/27. He passed away on 2/28/23. The patient received the primary COVID vaccine series and one booster dose.
Age: 95.0
Sex: M
Vaccine: COVID19
Symptoms: Superinfection
Clinical narrative: Patient with history of atrial fibrillation, dementia, CKD, and stroke. He was brought to the ED by EMS on 2/20/23 for lethargy and weakness as noted by his nursing home staff. Per EMS, the patient had a fall the day prior but was evaluated by EMS and was determined he could stay home. He was found to have a fever with a temp of 104.2. A COVID PCR test performed in the ED resulted positive. He was admitted 2/20-2/28. He was diagnosed with COVID-pneumonia and superimposed bacterial pneumonia. Initially he was treated with broad spectrum antibiotics and steroids with improvement in symptoms, however the patient's condition worsened on 2/25. He had increased oxygen needs during his admission, and ultimately was transitioned to comfort cares on 2/27. He passed away on 2/28/23. The patient received the primary COVID vaccine series and one booster dose.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Adult failure to thrive, Chronic obstructive pulmonary disease, Pulmonary embolism
Clinical narrative: I26.99 PULMONARY EMBOLISM, UNSPECIFIED. 11/12/2021 COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) I26.99 PULMONARY EMBOLISM, UNSPECIFIED. 11/12/2021 FAILURE TO THRIVE SYNDROME, ADULT
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza, Ischaemic stroke
Clinical narrative: I63.9 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 2/13/2023 INFLUENZA I63.9 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 2/13/2023 ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY
Age: 40.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: VACCINE ADMINISTERED OUTSIDE OF THE SUGGESTED ADMINISTRATION DATE OF USE.
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Asthenia, COVID-19, Chills, Cough
Clinical narrative: Patient with history of COPD and atrial fibrillation. He was brought to the ED by EMS on 2/22/23 for evaluation of weakness that began the day prior. He additionally reports fevers, chills, headache, cough, and some shortness of breath. A COVID PCR test performed in the ED resulted positive. He was admitted 2/22/23-2/25/23 with discharge diagnoses including COVID-19 infection, generalized weakness due to COVID, and acute hypoxic respiratory failure. Of note, the patient has received the primary COVID vaccine series, two boosters, and the bivalent vaccine.
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: Dyspnoea, Headache, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Patient with history of COPD and atrial fibrillation. He was brought to the ED by EMS on 2/22/23 for evaluation of weakness that began the day prior. He additionally reports fevers, chills, headache, cough, and some shortness of breath. A COVID PCR test performed in the ED resulted positive. He was admitted 2/22/23-2/25/23 with discharge diagnoses including COVID-19 infection, generalized weakness due to COVID, and acute hypoxic respiratory failure. Of note, the patient has received the primary COVID vaccine series, two boosters, and the bivalent vaccine.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Femur fracture, Fracture displacement, Major depression
Clinical narrative: J96.00 ACUTE RESPIRATORY FAILURE 1/17/2023 MAJOR DEPRESSIVE DISORDER, RECURRENT EPISODE, MODERATE    RIGHT INTERTROCHANTERIC FEMUR FX, DISPL INIT
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Hypoxia, Respiratory failure
Clinical narrative: ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE RESPIRATORY FAILURE, UNSPECIFIED ACUITY HYPOXIA
Age: 11.0
Sex: F
Vaccine: DTAP
Symptoms: Headache, Pain, Pyrexia, Vomiting
Clinical narrative: Vomiting,  severe head ach. Body aches, fever
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Dementia Alzheimer's type
Clinical narrative: J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 1/8/2023 ALZHEIMERS DISEASE
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, Cough, Dyspnoea, Myalgia
Clinical narrative: Patient with history of COPD. She was brought in the ED by EMS on 2/23/23 for sneezing, shortness of breath, cough, fever, and myalgias. A COVID PCR test was done in the ED which resulted positive. She required supplemental O2 to maintain normal O2 saturations. Ultimately she was admitted 2/23/23 - 2/27/23. Dexamethasone 6mg daily was started 2/23/23. Discharge diagnoses included acute hypoxic respiratory failure due to COVID-19 infection, among other diagnoses. Patient required supplemental O2 during admission (2 liters) but was eventually weaned to room air.  Of note, the patient has received the primary COVID vaccine series and two boosters.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive, Sneezing
Clinical narrative: Patient with history of COPD. She was brought in the ED by EMS on 2/23/23 for sneezing, shortness of breath, cough, fever, and myalgias. A COVID PCR test was done in the ED which resulted positive. She required supplemental O2 to maintain normal O2 saturations. Ultimately she was admitted 2/23/23 - 2/27/23. Dexamethasone 6mg daily was started 2/23/23. Discharge diagnoses included acute hypoxic respiratory failure due to COVID-19 infection, among other diagnoses. Patient required supplemental O2 during admission (2 liters) but was eventually weaned to room air.  Of note, the patient has received the primary COVID vaccine series and two boosters.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Angina pectoris
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE STABLE ANGINA ANGINA, UNSPECIFIED
Age: 42.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: VACCINE ADMINISTERED OUTSIDE OF THE SUGGESTED ADMINISTRATION DATE OF USE.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia
Clinical narrative: HYPOXIA
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Angina pectoris, Angioedema, Cardiac assistance device user, Cardiac failure congestive
Clinical narrative: COAGULOPATHY, UNSPECIFIED TYPE 10/10/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA ANGIOEDEMA, INIT 8/21/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA COAGULOPATHY, UNSPECIFIED TYPE 10/10/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA    GASTROPATHY    HX OF STROKE WO RESIDUAL DEFICITS ANGIOEDEMA, INIT 8/21/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA    GASTROPATHY    HX OF STROKE WO RESIDUAL DEFICITS COAGULOPATHY, UNSPECIFIED TYPE 10/10/2022 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED ANGIOEDEMA, INIT 8/21/2022 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED COAGULOPATHY, UNSPECIFIED TYPE 10/10/2022 NONTRAUMATIC ACUTE KIDNEY INJURY  ANGIOEDEMA, INIT 8/21/2022 NONTRAUMATIC ACUTE KIDNEY INJURY COAGULOPATHY, UNSPECIFIED TYPE 10/10/2022 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED ANGIOEDEMA, INIT 8/21/2022 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED COAGULOPATHY, UNSPECIFIED TYPE 10/10/2022 GI HEMORRHAGE ANGIOEDEMA, INIT 8/21/2022 GI HEMORRHAGE COAGULOPATHY, UNSPECIFIED TYPE 10/10/2022 CHF, STAGE D ANGIOEDEMA, INIT 8/21/2022 CHF, STAGE D COAGULOPATHY, UNSPECIFIED TYPE 10/10/2022 PRESENCE OF HEART ASSIST DEVICE    THROMBOCYTOPENIA, UNSPECIFIED. ANGIOEDEMA, INIT 8/21/2022 PRESENCE OF HEART ASSIST DEVICE    THROMBOCYTOPENIA, UNSPECIFIED. COAGULOPATHY, UNSPECIFIED TYPE 10/10/2022 ALTERED MENTAL STATUS, UNSPECIFIED ANGIOEDEMA, INIT 8/21/2022 ALTERED MENTAL STATUS, UNSPECIFIED
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Coagulopathy, Coronary artery disease, Gastric disorder, Gastrointestinal haemorrhage, Mental status changes
Clinical narrative: COAGULOPATHY, UNSPECIFIED TYPE 10/10/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA ANGIOEDEMA, INIT 8/21/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA COAGULOPATHY, UNSPECIFIED TYPE 10/10/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA    GASTROPATHY    HX OF STROKE WO RESIDUAL DEFICITS ANGIOEDEMA, INIT 8/21/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA    GASTROPATHY    HX OF STROKE WO RESIDUAL DEFICITS COAGULOPATHY, UNSPECIFIED TYPE 10/10/2022 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED ANGIOEDEMA, INIT 8/21/2022 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED COAGULOPATHY, UNSPECIFIED TYPE 10/10/2022 NONTRAUMATIC ACUTE KIDNEY INJURY  ANGIOEDEMA, INIT 8/21/2022 NONTRAUMATIC ACUTE KIDNEY INJURY COAGULOPATHY, UNSPECIFIED TYPE 10/10/2022 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED ANGIOEDEMA, INIT 8/21/2022 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED COAGULOPATHY, UNSPECIFIED TYPE 10/10/2022 GI HEMORRHAGE ANGIOEDEMA, INIT 8/21/2022 GI HEMORRHAGE COAGULOPATHY, UNSPECIFIED TYPE 10/10/2022 CHF, STAGE D ANGIOEDEMA, INIT 8/21/2022 CHF, STAGE D COAGULOPATHY, UNSPECIFIED TYPE 10/10/2022 PRESENCE OF HEART ASSIST DEVICE    THROMBOCYTOPENIA, UNSPECIFIED. ANGIOEDEMA, INIT 8/21/2022 PRESENCE OF HEART ASSIST DEVICE    THROMBOCYTOPENIA, UNSPECIFIED. COAGULOPATHY, UNSPECIFIED TYPE 10/10/2022 ALTERED MENTAL STATUS, UNSPECIFIED ANGIOEDEMA, INIT 8/21/2022 ALTERED MENTAL STATUS, UNSPECIFIED
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Thrombocytopenia
Clinical narrative: COAGULOPATHY, UNSPECIFIED TYPE 10/10/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA ANGIOEDEMA, INIT 8/21/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA COAGULOPATHY, UNSPECIFIED TYPE 10/10/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA    GASTROPATHY    HX OF STROKE WO RESIDUAL DEFICITS ANGIOEDEMA, INIT 8/21/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA    GASTROPATHY    HX OF STROKE WO RESIDUAL DEFICITS COAGULOPATHY, UNSPECIFIED TYPE 10/10/2022 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED ANGIOEDEMA, INIT 8/21/2022 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED COAGULOPATHY, UNSPECIFIED TYPE 10/10/2022 NONTRAUMATIC ACUTE KIDNEY INJURY  ANGIOEDEMA, INIT 8/21/2022 NONTRAUMATIC ACUTE KIDNEY INJURY COAGULOPATHY, UNSPECIFIED TYPE 10/10/2022 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED ANGIOEDEMA, INIT 8/21/2022 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED COAGULOPATHY, UNSPECIFIED TYPE 10/10/2022 GI HEMORRHAGE ANGIOEDEMA, INIT 8/21/2022 GI HEMORRHAGE COAGULOPATHY, UNSPECIFIED TYPE 10/10/2022 CHF, STAGE D ANGIOEDEMA, INIT 8/21/2022 CHF, STAGE D COAGULOPATHY, UNSPECIFIED TYPE 10/10/2022 PRESENCE OF HEART ASSIST DEVICE    THROMBOCYTOPENIA, UNSPECIFIED. ANGIOEDEMA, INIT 8/21/2022 PRESENCE OF HEART ASSIST DEVICE    THROMBOCYTOPENIA, UNSPECIFIED. COAGULOPATHY, UNSPECIFIED TYPE 10/10/2022 ALTERED MENTAL STATUS, UNSPECIFIED ANGIOEDEMA, INIT 8/21/2022 ALTERED MENTAL STATUS, UNSPECIFIED
Age: 13.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: VACCINE ADMINISTERED OUTSIDE OF THE SUGGESTED ADMINISTRATION DATE OF USE.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Anaemia, Anxiety disorder, Chemotherapy, Deep vein thrombosis, Neuropathy peripheral
Clinical narrative: G62.0 CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY, SUBSEQ 1/7/2023 UNSPECIFIED ANXIETY DISORDER G62.9 NEUROPATHY 12/30/2022 UNSPECIFIED ANXIETY DISORDER I82.401 ACUTE DVT OF RIGHT LEG, UNSPECIFIED VEIN 1/7/2023 UNSPECIFIED ANXIETY DISORDER G62.0 CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY, SUBSEQ 1/7/2023 ANEMIA G62.9 NEUROPATHY 12/30/2022 ANEMIA I82.401 ACUTE DVT OF RIGHT LEG, UNSPECIFIED VEIN 1/7/2023 ANEMIA G62.0 CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY, SUBSEQ 1/7/2023 PANCYTOPENIA DUE TO ANTINEOPLASTIC CHEMOTHERAPY G62.9 NEUROPATHY 12/30/2022 PANCYTOPENIA DUE TO ANTINEOPLASTIC CHEMOTHERAPY I82.401 ACUTE DVT OF RIGHT LEG, UNSPECIFIED VEIN 1/7/2023 PANCYTOPENIA DUE TO ANTINEOPLASTIC CHEMOTHERAPY G62.0 CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY, SUBSEQ 1/7/2023 PANCYTOPENIA G62.9 NEUROPATHY 12/30/2022 PANCYTOPENIA I82.401 ACUTE DVT OF RIGHT LEG, UNSPECIFIED VEIN 1/7/2023 PANCYTOPENIA
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pancytopenia
Clinical narrative: G62.0 CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY, SUBSEQ 1/7/2023 UNSPECIFIED ANXIETY DISORDER G62.9 NEUROPATHY 12/30/2022 UNSPECIFIED ANXIETY DISORDER I82.401 ACUTE DVT OF RIGHT LEG, UNSPECIFIED VEIN 1/7/2023 UNSPECIFIED ANXIETY DISORDER G62.0 CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY, SUBSEQ 1/7/2023 ANEMIA G62.9 NEUROPATHY 12/30/2022 ANEMIA I82.401 ACUTE DVT OF RIGHT LEG, UNSPECIFIED VEIN 1/7/2023 ANEMIA G62.0 CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY, SUBSEQ 1/7/2023 PANCYTOPENIA DUE TO ANTINEOPLASTIC CHEMOTHERAPY G62.9 NEUROPATHY 12/30/2022 PANCYTOPENIA DUE TO ANTINEOPLASTIC CHEMOTHERAPY I82.401 ACUTE DVT OF RIGHT LEG, UNSPECIFIED VEIN 1/7/2023 PANCYTOPENIA DUE TO ANTINEOPLASTIC CHEMOTHERAPY G62.0 CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY, SUBSEQ 1/7/2023 PANCYTOPENIA G62.9 NEUROPATHY 12/30/2022 PANCYTOPENIA I82.401 ACUTE DVT OF RIGHT LEG, UNSPECIFIED VEIN 1/7/2023 PANCYTOPENIA
Age: 50.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: VACCINE ADMINISTERED OUTSIDE OF THE SUGGESTED ADMINISTRATION DATE OF USE.
Age: 59.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute respiratory failure
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE
Age: 51.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: VACCINE ADMINISTERED OUTSIDE OF THE SUGGESTED ADMINISTRATION DATE OF USE.
Age: 13.0
Sex: F
Vaccine: HPV9
Symptoms: Dizziness, Dyspnoea, Erythema, Swelling, Tenderness
Clinical narrative: Initially, 1.5 weeks of local redness, swelling and tenderness that resolved. Presently, she has 2 weeks of dizziness and a feeling of shortness of air requiring deep breaths to feel better
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebral artery occlusion, Cerebrovascular accident
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE STROKE DUE TO OCCLUSION OF RIGHT MIDDLE CEREBRAL ARTERY
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, COVID-19 pneumonia, Fall, Mental status changes
Clinical narrative: Patient with history of diabetes type II. She was brought to the ED by EMS on 2/23/23 for weakness. She reports she fell out of her recliner and couldn't get up so called 911. Additionally, her family reports she has had decreased mental alertness. A COVID PCR test performed in the ED resulted positive. Ultimately the patient was admitted 2/23/23-3/3/23 for COVID-19 pneumonia with sepsis. She was treated with IV ceftriaxone and azithromycin, as well as dexamethasone 6 mg daily and remdesivir. She required 3L supplemental O2, and was discharged still on supplemental oxygen. Of note, the patient has received the primary COVID vaccine series and two boosters.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, SARS-CoV-2 test positive, Sepsis
Clinical narrative: Patient with history of diabetes type II. She was brought to the ED by EMS on 2/23/23 for weakness. She reports she fell out of her recliner and couldn't get up so called 911. Additionally, her family reports she has had decreased mental alertness. A COVID PCR test performed in the ED resulted positive. Ultimately the patient was admitted 2/23/23-3/3/23 for COVID-19 pneumonia with sepsis. She was treated with IV ceftriaxone and azithromycin, as well as dexamethasone 6 mg daily and remdesivir. She required 3L supplemental O2, and was discharged still on supplemental oxygen. Of note, the patient has received the primary COVID vaccine series and two boosters.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 4 vaccines Moderna 7/2/21 lot# 049C21A;  Moderna 7/30/21 lot# 049C;  Moderna 2/9/22 lot# 042J21A;  Moderna 8/2/22 Lot# 037A22B
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Pfizer 2/24/21 lot# EL9267;  Pfizer 3/17/21 lot# EN6205;  Pfizer 12/20/21 lot# 33130BA
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Pfizer 12/7/21 lot# FH8027;  Pfizer 1/6/22 lot# FJ1611
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Moderna 2/24/21 lotA3 010A21a;  MOderna 3/24/21 lot# 047A21a;  Moderna 1/14/22 lot# 066h21a
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Symptom recurrence
Clinical narrative: ACUTE NON ST ELEVATION MI 4/25/2022 -- RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines ; Pfizer 4/5/21 lot# Ew0150;  Pfizer 4/26/21 lot# ER8735;  Pfizer 8/20/21 lot# Ew0180
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema of eyelid, Eye oedema, Eye pain
Clinical narrative: Right eye (only) - Edema & Erythema and mild to moderate pain lasting 24 hours. Treated with otc benedryl with no effect. Treated with cold compress alleviating the pain and some swelling.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Flushing, Malaise, Pyrexia
Clinical narrative: 3/19/2023 In the afternoon I was flushed and had a fever of 102.  I went to Urgent Care where they ran a rapid COVID-19 test, positive.  Doctor Proscribed anti-COVID-19 medication, but which one specifically is not remembered.  Symptoms got better upon taking medication.  Developed a cough after starting the medication, painful to cough, but that was attributed to a fall that hurt participant ribs on 3/12.  Every day there was a check in by doctor and they proscribed an antibiotic and a steroid to help with symptoms.  Symptoms cleared up after a couple of days.   The cough lingered about 2 weeks.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: 3/19/2023 In the afternoon I was flushed and had a fever of 102.  I went to Urgent Care where they ran a rapid COVID-19 test, positive.  Doctor Proscribed anti-COVID-19 medication, but which one specifically is not remembered.  Symptoms got better upon taking medication.  Developed a cough after starting the medication, painful to cough, but that was attributed to a fall that hurt participant ribs on 3/12.  Every day there was a check in by doctor and they proscribed an antibiotic and a steroid to help with symptoms.  Symptoms cleared up after a couple of days.   The cough lingered about 2 weeks.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Angina pectoris
Clinical narrative: ANGINA, UNSPECIFIED
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Moderna 2/12/21 lot# 105MZ0a;  MOderna 3/12/21 lot# 010A21A
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Pulmonary embolism
Clinical narrative: ACUTE PULMONARY EMBOLISM
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Pfizer 4/8/21 lot# EW0053;  Pfizer 5/6/21 lot# Ew0182;  Pfizer 11/2/21 lot# FH8020;
Age: 55.0
Sex: F
Vaccine: PNC13
Symptoms: Expired product administered, No adverse event
Clinical narrative: VACCINE EXPIRED ON 05/31/23; ADMINISTERED ON 06/02/23. NO ADVERSE EFFECTS TO PATIENT.
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Arthralgia, Injection site pain
Clinical narrative: Patient has had upper arm/shoulder pain in his left arm since he received his vaccine
Age: 77.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 5 vaccines Pfizer 1/16/21 lot# EL1283;  Pfizer 2/3/21 lot#EL9265;  Pfizer 9/17/21 lot# Ew0179;  Pfizer 4/1/22 Lot# Fk9896;  Pfizer 10/7/22 lot# GJ2524;
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Pfizer 4/13/21 lot# Ew0150;  Pfizer 5/4/21 lot# EW0179
Age: 74.0
Sex: F
Vaccine: COVID19-2
Symptoms: Asthenia, COVID-19, Chills, Dysphagia, Ear discomfort
Clinical narrative: Contacted COVID  04/01/2023.  Symptoms--extremely sore throat, difficulty swallowing, chills, body aches, headache, sinus congestion, plugged ears, difficulty hearing, weakness.  Lasted through 04/22/2023.  Weakness continued for several weeks after symptoms done.  Treatment--Tylenol, amoxicillin 500 mg., Azelastine HCI nasal spray 0.1%, prednisone
Age: 74.0
Sex: F
Vaccine: COVID19-2
Symptoms: Headache, Hypoacusis, Influenza virus test negative, Oropharyngeal pain, Pain
Clinical narrative: Contacted COVID  04/01/2023.  Symptoms--extremely sore throat, difficulty swallowing, chills, body aches, headache, sinus congestion, plugged ears, difficulty hearing, weakness.  Lasted through 04/22/2023.  Weakness continued for several weeks after symptoms done.  Treatment--Tylenol, amoxicillin 500 mg., Azelastine HCI nasal spray 0.1%, prednisone
Age: 74.0
Sex: F
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive, Sinus congestion, Streptococcus test negative
Clinical narrative: Contacted COVID  04/01/2023.  Symptoms--extremely sore throat, difficulty swallowing, chills, body aches, headache, sinus congestion, plugged ears, difficulty hearing, weakness.  Lasted through 04/22/2023.  Weakness continued for several weeks after symptoms done.  Treatment--Tylenol, amoxicillin 500 mg., Azelastine HCI nasal spray 0.1%, prednisone
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Moderna 3/20/21 lot# 047A21a;  MOderna 4/17/21 lot# 040B21A;
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Chronic respiratory failure, Obstructive sleep apnoea syndrome, Respiratory failure
Clinical narrative: ADULT OBSTRUCTIVE SLEEP APNEA ACUTE RESPIRATORY FAILURE CHRONIC HYPOXEMIC RESPIRATORY FAILURE CHRONIC HYPERCAPNIC RESPIRATORY FAILURE
Age: 80.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, COVID-19, Chills, Chronic obstructive pulmonary disease, Condition aggravated
Clinical narrative: Patient with a history of COPD. She presented to the ED on 2/26/23 with a week's worth of symptoms including shortness of breath, cough, chills, and green phlegm. She notes she was exposed to a friend who tested positive for COVID. A COVID-19 PCR test performed in the ED resulted positive. She was placed on 2L supplemental O2 with O2 sats at 95%. Ultimately she was admitted 2/26/23-2/28/23 with discharge diagnoses including acute hypoxic respiratory failure d/t AECOPD, possible bacterial bronchitis, and COVID-19 infection. She was started on Dexamethasone 6mg daily (started 2/26) and required supplemental O2. She was eventually weaned to room air. Of note, the patient has received the primary COVID vaccine series and three boosters.
Age: 80.0
Sex: F
Vaccine: COVID19-2
Symptoms: Cough, Dyspnoea, Exposure to SARS-CoV-2, SARS-CoV-2 test positive, Sputum discoloured
Clinical narrative: Patient with a history of COPD. She presented to the ED on 2/26/23 with a week's worth of symptoms including shortness of breath, cough, chills, and green phlegm. She notes she was exposed to a friend who tested positive for COVID. A COVID-19 PCR test performed in the ED resulted positive. She was placed on 2L supplemental O2 with O2 sats at 95%. Ultimately she was admitted 2/26/23-2/28/23 with discharge diagnoses including acute hypoxic respiratory failure d/t AECOPD, possible bacterial bronchitis, and COVID-19 infection. She was started on Dexamethasone 6mg daily (started 2/26) and required supplemental O2. She was eventually weaned to room air. Of note, the patient has received the primary COVID vaccine series and three boosters.
Age: 41.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Expired Vaccine
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 5 vaccines ; Pfizer 2/27/21 lot# EN6202;  Pfizer 3/20/21 lot# EN6207;  Pfizer 9/27/21 lot# 30135BA;  Pfizer 4/18/22 lot# FJ4991;  Pfizer 9/12/22 Lot# GJ5342
Age: 69.0
Sex: F
Vaccine: COVID19-2
Symptoms: Discomfort, Eye pain, Eye swelling, Periorbital cellulitis, Periorbital swelling
Clinical narrative: On 5/19/2023, I had painless mild swelling around the left eye. On 5/29/2023, I woke up with worsened swelling and pain in the left eye. Since it was a holiday, and my doctor's office was closed, I went to the ER. At the ER, I was diagnosed with periorbital cellulitis. I was given a dose of clindamycin at the ER and then prescribed a week's worth of clindamycin to take at home. On 5/31/2023, I saw my PCP. She told me that the diagnosis was correct and that I was taking the right medication. However, she did say that my condition and that I should be taking antibiotics for a longer period, so she prescribed me another week's worth of clindamycin. At the time of this writing, my symptoms have improved, though I still have some swelling, which has dramatically decreased since I began taking the clindamycin. I also no longer have any discomfort.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines  Pfizer 4/8/21 lot# Ew0151;  Pfizer 5/3/21 lot# Ew0165
Age: 3.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, Underdose
Clinical narrative: Given wrong dose. Pt was given one dose of Pink cap w/ yellow border vaccine (10Micro g) and should have received one dose of the blue cap w/ gray border (25 micro g)
Age: 1.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Localized redness and swelling around the injection site.  Ice applied.to reaction site
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Deep vein thrombosis, Pulmonary embolism
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN PULMONARY EMBOLISM, UNSPECIFIED.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Pfizer 2/1/21 lot# EL9265;  Pfizer 2/22/21 lot# EM9810
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Hypoxia, Respiratory failure
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE RESPIRATORY FAILURE, UNSPECIFIED ACUITY HYPOXIA
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Melanocytic naevus, Skin depigmentation, Skin discolouration, Vitiligo
Clinical narrative: Developed Vitiligo and Halo Nevi.  Didn't notice right away and didn't associate the timing of events until I started looking at pictures of myself to see when this began (2021).  Have been going to a dermatologist.  Was not in my record in 2020, but I did mention the development of white spots in my Aug 2021 annual appointment.   Depigmented patches distributed on the left ventral distal forearm, superior lumbar spine, and periumbilical skin
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension, Hypoxia
Clinical narrative: HYPOTENSION 10/20/2022 HYPOTENSION HYPOXIA 11/9/2022 HYPOTENSION
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 4 vaccines  Moderna 2/14/21 lot# 038K20A;  Moderna 3/14/21 lot# 044A21A;  Moderna 10/27/21 lot#939904 ; Moderna 6/16/22 lot# 059A22A;
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Symptom recurrence
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE 2/28/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 1.67
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, Underdose
Clinical narrative: Given wrong dose. Pt was given one dose of Pink cap w/ yellow border vaccine (10Micro g) and should have received one dose of the blue cap w/ gray border (25 micro g)
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Hyperkalaemia, Hypernatraemia, Respiratory failure
Clinical narrative: ACUTE HYPERCAPNIC RESPIRATORY FAILURE 11/6/2022 HYPERNATREMIA RESPIRATORY FAILURE, UNSPECIFIED ACUITY 11/30/2022 HYPERNATREMIA ACUTE HYPERCAPNIC RESPIRATORY FAILURE 11/6/2022 HYPERKALEMIA RESPIRATORY FAILURE, UNSPECIFIED ACUITY 11/30/2022 HYPERKALEMIA
Age: 83.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 4 vaccines Pfizer 2/2/21 lot# EM980;  Pfizer 2/24/21 lot# EN2198;  Pfizer 9/27/21 Lot# 3013SBA;  11/11/22 Pfizer Lot# GJ6665
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Pfizer 5/18/21 lot# Ew0172;  Pfizer 6/16/21 Lot# Ew0172
Age: 91.0
Sex: M
Vaccine: COVID19-2
Symptoms: Altered state of consciousness, COVID-19, Dyspnoea, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Patient brought to the ED by EMS on 2/28/23 for shortness of breath and fever. Per EMS the patient was noted by assisted living facility staff to have had increased work of breathing and change in his level of consciousness. In the ED he was noted to have a fever. A COVID PCR test done in the ED returned positive. He was admitted 2/28/23 - 3/17/23 and was found to have sepsis secondary to UTI and COVID-19 infection. The patient did not improve with treatment and family ultimately decided to transition to comfort cares. During admission, patient completed dexamethasone 6 mg daily. He was discharged to an assisted living facility with hospice. Of note, the patient has received the primary COVID vaccine series and two boosters.
Age: 91.0
Sex: M
Vaccine: COVID19-2
Symptoms: Sepsis, Urinary tract infection
Clinical narrative: Patient brought to the ED by EMS on 2/28/23 for shortness of breath and fever. Per EMS the patient was noted by assisted living facility staff to have had increased work of breathing and change in his level of consciousness. In the ED he was noted to have a fever. A COVID PCR test done in the ED returned positive. He was admitted 2/28/23 - 3/17/23 and was found to have sepsis secondary to UTI and COVID-19 infection. The patient did not improve with treatment and family ultimately decided to transition to comfort cares. During admission, patient completed dexamethasone 6 mg daily. He was discharged to an assisted living facility with hospice. Of note, the patient has received the primary COVID vaccine series and two boosters.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Cardiac failure congestive, Cardiogenic shock, Dilated cardiomyopathy, Dyspnoea
Clinical narrative: HYPOTENSION 10/25/2022 HYPOXIA ACUTE RESPIRATORY FAILURE 10/27/2022 HYPOXIA ACUTE HYPOXEMIC RESPIRATORY FAILURE 1/6/2022 HYPOXIA ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 3/8/2022 HYPOXIA HYPOXIA 10/25/2022 HYPOXIA CARDIOGENIC SHOCK 10/25/2022 HYPOXIA HYPOTENSION 10/25/2022 ACUTE RESPIRATORY FAILURE ACUTE RESPIRATORY FAILURE 10/27/2022 ACUTE RESPIRATORY FAILURE ACUTE HYPOXEMIC RESPIRATORY FAILURE 1/6/2022 ACUTE RESPIRATORY FAILURE ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 3/8/2022 ACUTE RESPIRATORY FAILURE HYPOXIA 10/25/2022 ACUTE RESPIRATORY FAILURE  CARDIOGENIC SHOCK 10/25/2022 ACUTE RESPIRATORY FAILURE HYPOTENSION 10/25/2022 IMMUNOCOMPROMISED DUE TO MEDICATION ACUTE RESPIRATORY FAILURE 10/27/2022 IMMUNOCOMPROMISED DUE TO MEDICATION ACUTE HYPOXEMIC RESPIRATORY FAILURE 1/6/2022 IMMUNOCOMPROMISED DUE TO MEDICATION ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 3/8/2022 IMMUNOCOMPROMISED DUE TO MEDICATION HYPOXIA 10/25/2022 IMMUNOCOMPROMISED DUE TO MEDICATION CARDIOGENIC SHOCK 10/25/2022 IMMUNOCOMPROMISED DUE TO MEDICATION HYPOTENSION 10/25/2022 DILATED CARDIOMYOPATHY ACUTE RESPIRATORY FAILURE 10/27/2022 DILATED CARDIOMYOPATHY  ACUTE HYPOXEMIC RESPIRATORY FAILURE 1/6/2022 DILATED CARDIOMYOPATHY ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 3/8/2022 DILATED CARDIOMYOPATHY HYPOXIA 10/25/2022 DILATED CARDIOMYOPATHY CARDIOGENIC SHOCK 10/25/2022 DILATED CARDIOMYOPATHY HYPOTENSION 10/25/2022 PULMONARY SARCOIDOSIS  ACUTE RESPIRATORY FAILURE 10/27/2022 PULMONARY SARCOIDOSIS ACUTE HYPOXEMIC RESPIRATORY FAILURE 1/6/2022 PULMONARY SARCOIDOSIS ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 3/8/2022 PULMONARY SARCOIDOSIS HYPOXIA 10/25/2022 PULMONARY SARCOIDOSIS CARDIOGENIC SHOCK 10/25/2022 PULMONARY SARCOIDOSIS HYPOTENSION 10/25/2022 SHORTNESS OF BREATH ACUTE RESPIRATORY FAILURE 10/27/2022 SHORTNESS OF BREATH ACUTE HYPOXEMIC RESPIRATORY FAILURE 1/6/2022 SHORTNESS OF BREATH ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 3/8/2022 SHORTNESS OF BREATH HYPOXIA 10/25/2022 SHORTNESS OF BREATH CARDIOGENIC SHOCK 10/25/2022 SHORTNESS OF BREATH HYPOTENSION 10/25/2022 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED ACUTE RESPIRATORY FAILURE 10/27/2022 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED ACUTE HYPOXEMIC RESPIRATORY FAILURE 1/6/2022 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 3/8/2022 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED HYPOXIA 10/25/2022 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED CARDIOGENIC SHOCK 10/25/2022 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED